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1723-61 Hemodynamic Effects of Graded Oral Doses of a New
Dopaminergic Analogue CHF 1035 In Patients with
Congestive Heart Failure
lACC February 1995
5 mg 10 mg 15 mg
PD AD PD AD PD AD
PCWP 22 ± 5 18 ± 4* 20 ± 6 16 ± 9* 21 ± 7 16 ± 6*
CI 3± 1 3.4 ± 1* 2.7 ± 1 3.4 ± 1* 3±1 4 ± 1*
SVI 39 ± 12 43 ± 11 38± 7 45 ± 10* 40± 10 49 ± 11*
SVR 1243 ± 27 1052 ± 265 1382 ± 45 1009±315 1359 ± 36 881 ± 257*
HR 74 ± 11 78 ± 11* 70 ± 11 76 ± 12 74 ± 12 80 ± 10*
8Pm 85 ± 12 82 ± 12 85 ± 10 77 ± 13* 87 ± 11 79 ± 12*
NE 299 ± 135 301±156 285 ± 244 244 ± 88* 340 ± 162 308 ± 133
E 56 ± 29 42 ± 21* 65 ± 42 62 ±44 53 ± 25 58 ± 24
*: p < 005
No changes in hemodynamic or neurohormonal parameters occurred af-
ter P administration. Our results demonstrate that CHF 1035 induce a signifi-
cant improvement in hemodynamic parameters in pts with CHF. In particular
it is able to induce systemic vasodilatation without any reflex increase in cate-
cholamine plasma levels. Thus CHF 1035 appears to be a promising drug for
the treatment of CHF.
Transcatheter treatment of atrioventricular nodal reentrant tachycardia
(AVNRT) modifies but frequently does not eliminate the electrophysiologic
substrate for reentry. The extent of modification required thus remains un-
clear. High recurrence rates have been reported when single AV nodal echos
(AVNe) remain inducible. We, therefore, prospectively evaluated the charac-
teristics of AVNe pre and postAV nodal modification.
Results: Ablation was deemed successful when sustained AVNRT could
not be induced on isoproternol (ISO). After successful ablation, AVNe was in-
ducible in 24 pts and noninducible in 72 pts. Other electrophysiologic param-
eters in these two groups were comparable with similar increases in 1: 1 AV
block cycle lengths (356 to 413 and 368 to 400 msec, p < 0.005) and AVNERP
(258 to 317 and 264 to 313 msec, p < 0.001) pre to post ablation. In Group 1
patients, persistent AVNes following successful ablation (good echoes) were
associated with an increase in AH interval in all but one patient as compared
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Electrophysiologic Endpoints of Successful
Radlofrequency Catheter Modification for
Atrioventricular Nodal Reentrant Tachycardia. Are
There "Good" and "Bad" Persistent Echoes?
Anwer Dhala. Zalmen Blanck, Margaret Budziszewski, Michael Biehl,
Sanjay Deshpande, Jasbir Sra, Mohammad R. Jazayeri, Masood Akhtar. Sinai
Samaritan/St. Luke'5 Medical Center, Milwaukee, WI
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1724-1 1Characteristics of Successful Posterior Septal Sites
to Cure Atrioventricular Node Reentry Using a
Thermistor Controlled Catheter System
Rafe Chamberlain Webber, John N. Hill, Joseph J. Evans, Richard I. Fogel, Eric
N. Prystowsky. Indiana Heart Institute, Indianapolis, IN
We prospectively investigated in 55 pts characteristics of successful radiofre-
quency ablation (RFA) sites to cure AVN reentry (AVNRT) using a thermistor
tipped catheter system with a posterior (slow pathway) approach. RFA suc-
cess (SI was :0:2 AVNRT echos after RFA; only 1 pt had AVNRT at follow-up.
There were 166 RFA [55 S; 111 failure (F)], with 3 ± 3/pt. Local atrial electro-
gram morphology was-A (low to isoelectric to high frequency); B (low to
high frequency); and C (:::2 high frequency components). Differences with S
vs F, respectively. are: atrial amplitude (396 ± 181 vs 357 ± 205 /Lv' P < 0.001);
ventricular amp. (3.0 ± 1.6 vs 2.7 ± 1.6 mV, p < 0.001); time to onset of junc-
tional tachycardia (JT) (2.1 ± 1.9 vs 4.6 ± 6.1 sec, p < 0.05); duration of JT
1146 ± 8.6 vs 11.6± 7.7 sec, p < 0.001); CL ofJT(481 ± 92vs 511 ± 120
ms, p < 0.0011; and change in CL of JT during RFA (-34 ± 113 vs +23 ± 128
ms, p < 0.03). Of note, continuous JT was more common at S sites (46% vs
21 %), and JT occurred in :0:7.5 sec at all S sites. No differences between Svs
F were in: power(46.8 ± 7.5 vs 44.5 ± 8.6 W); catheter tip temp. (52.6 ± 4.6
vs 49.3 ± 5.5"C); atrial electrogram duration (66 ± 20 vs 66 ± 19 ms); ortype
of local atrial electrogram. We conclude: 11 Successful RFA to cure AVNRT
more frequently occurs with rapid onset of continuous junctional tachycardia
with a CL that shortens before termination and, 2) there is no specific local
atrial electrogram morphology that predicts success.
ABSTRACfS
ther effect. There was a 16 msec increase in the PR interval at rest with 2 mg
(159 to 175 msec, P < 0.01) with no further change at 5 mg. The increase in
PR persisted even during peak exercise (115, 134 & 149 msec with placebo.
2 &5 mg, P < 0.001). The drug had no effect on resting &exercise blood
pressure, exercise time, V02, anaerobic threshold, ventilatory indices, and
epinephrine, norepinephrine or aldosterone at peak exercise. However. SDZ
WAG 994 completely suppressed the normal increase in plasma renin activ-
ity(PRA) with exercise (P < 0.01). An interesting and unexpected finding was
a dose-dependent increase in ANF seen both at rest and peak exercise (P <
0.01). These findings suggest that a single dose of this oral adenosine A, se-
lective agonist, has the expected negative chronotropic &dromotropic prop-
erties in man, even during exercise when circulating catecholamines were
very high (epinephrine 299 ± 220 pg/ml, norepinephrine 1947 ± 998 pg/ml)
without any adverse cardiovascular effects. Its effects on PRA &ANF suggest
that SDZ WAG 994 may also be an important neurohormonal modulator in
man.
Carmine Morisco, Bruno Ricciardelli, Luigi Argenziano, Virgilio Rendina,
Guido laccarino, Carmine Vecchione, Alberto Umile 1, Massimo Volpe
Bruno Trimarco. I Clinica Medica Universita "FEDERICO II" Napoli, Italy; i Chiesi
Farmaceutici s.p.A., Italy
We investigated in a randomized double-blind study the hemodynamic ef-
fects of 3 single oral doses (5, 10 and 15 mg) of a new dopaminergic ana-
logue (CHF 1035) VS placebo (P) in 18 patients (pts) with congestive hea rt fail-
ure (CH F) (ejection fraction 25 ± 7%). Each patient received on 3 consecutive
study-days 2 active doses of CHF 1035 and 1 Pdose. The following measure-
ments were performed using a Swan-Ganz catheter pre-dose (PO) and from
20 to 300 min after dosing (AD) levery 20 min for the first 2 hours, then ev-
ery 60 min): pulmonary capillary wedge pressure (PCWP) (mmHg), cardiac
index ICI) (I/min/m2), stroke volume index (ml/min/m2), systemic vascular re-
sistance (SVR) (dyne. sec· cm-5), heart rate (HR) Ibpm). mean blood pressure
(BPm) (mmHg). Plasma levels of norepinephrine (NE) (pg/ml) and epinephrine
(E) (pg/ml) were also assessed before and 140 min after CHF 1035 or P ad-
ministration. The hemodynamic (peak value) and neurohormonal parameters
showed the following changes after CHF 1035 administration.
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Evaluation of the Antianginal and Anti·ischemic
Effects of the Sinus Node Inhibitor Zatebradine Used
in Combination with Extended·Release Nifedipine In
Patients with Angina Pectoris
William Frishman, Carl Pepine, Robert WeiSS, Wolfgang Baiker, Zatebradine
Multicenter Study Group. Albert Einstein College ofMedicine, Bronx, NY
Zatebradine (Z) is a directsinus node inhibitor which is orally active and, unlike
p-adrenergic blockers, has no effect on blood pressure, vascular resistances,
and ventricular contractility. We evaluated the anginal and anti-ischemic ef-
fects of Z 15 mg administered twice daily) and placebo in 124 patients (pts)
already receiving 3D-90 mg of extended-release nifedipine once daily, whose
treadmill exercise tolerance was still limited. After 2-3 wks of single-blind
placebo therapy with reproducible exercise-induced angina on the treadmill,
pts were randomized to receive in double-blind fashion twice daily Z (n = 64)
or twice daily placebo (n = 60) in addition to nifedipine. Subjects were fol-
lowed with serial exercise tests 13 hrs post dose) for 4 wks and angina diaries
were maintained. At 4 wks, Z was shown to reduce resting heart rate (HR) in
contrast to placebo (12.9 ± 1,23 vs 2.3 ± 1.6 bpm, p < 0.0001), and at the
end of comparable stages of exercise (Bruce). Z reduced HR in contrast to
placebo (16.7 ± 1.2 vs 3.4 ± 1.2 bpm, p < 0.001). Despite these significant
effects on HR with Z at rest and exercise, there were no additional antiang-
inal benefits of Z from placebo baseline in measurements of total exercise
duration, time to 1 mm ST segment depression, or time to onset of angina.
Z appears to provide no additional antianginal benefit to pts already receiving
nifedipine, and raises questions regarding the benefit of HR reduction alone
as an antianginal approach in pts.
128A
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to AVNes seen either preablation or during ablation attempts when tachycar-
dia was still inducible (bad echoes) (366.9 ± 113 vs 279.6 ± 80 msec, p <
0.001). In Group 2 patients, when the AH interval of AVNes was unchanged
from baseline, further ablation attempts were required to achieve nonin-
ducibility and also resulted in abolition of dual physiology. During a mean
follow-up of 11 ± 4 months, only one of the 96 patients had a recurrence.
Conclusion: Successful modification of the slow pathway for AVNRT is
associated with persistent AVNes with longer AH intervals possibly due to
slow pathway injury or multiple slow pathways. Post ablation, AVNes with
unchanged AH interval from baseline require further ablation for successful
outcome.
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1724-31 Long RP Tachycardia: Can Mode of Termination by
Adenosine Differentiate Atrial from Atypical AV Node
Re-entry Tachycardia?
John Hill, Rafe Chamberlain Webber, Leandro Zimerman, Hossein Shenasa,
Richard Fogel, Marcus Wharton, Eric Prystowsky. Indiana Heart Institute,
Indianapolis, IN; Duke University Medical Center, Durham, NC
Discrimination between long RP tachycardias can be difficult but is essential
when ablative therapy is contemplated. After diagnosis by EP study, we ad-
ministered adenosine (Ad) 12 mg to pts during atrial (AT, n ~ 24) or atypical
AV node (ATYP, n = 7) tachycardia (tc). Tc cycle length (Cl) and component in-
tervals were measured before and after Ad. Ad caused termination (term) in
all AT without prior AV node block. In tc without substantial Cl variability, first
change (8) in Cl after Ad was located in either H-H or A-A intervals. For cycles
between 8 and term in atrium (a) or ventricle (v), presence of Cl oscillation
(Osc) and net change of A-A were assessed and intervals were examined for
Pearson r linear correlation patterns.
1. Before Ad age sex CL A-H H-A
(y) (m, f) Ims) (ms) (ms)
AT 43 ± 17 2, 22 425 ± 94 82 ± 52 332 ± 107
ATYP 38 ± 20 3, 4 387 ± 107 113 ± 70 289 ± 86
p: ns <0.005 ns ns ns
2. After Ad 8 Ose term 8 to term net 11M
(A-A, H-H) (nJ (a, vi (cyclesl (msl
AT 17 0 15 10 14 3.9± 14 28± 29
ATYP 2 2 6 2 5 3.5 ± 1.7 25 ± 24
p: ns ns ns ns ns ns ns
3. A-Avs A-H A-Avs H-A
(term a) (term v) (term a) (term vi
No. of Correlations AT 6/10 2/14 4/10 13/14
with p < 0.05 for r ATYP 1/2 1/5 2/2 3/5
P (AT vs ATYP): ns ns ns ns
ABSTRACTS 129A
The earliest atrial activation during SF reentry was recorded at the His bun-
dle electrogram, while during FS reentry it was recorded anterior and inferior
to the coronary sinus ostium. A single radiofrequency (RF) application at the
earliest atrial site during FS reentry eliminated both the FS echoes and the ret-
rograde discontinuous curve, while maintaining a discontinuous antegrade
curve (figure) and SF reentry (non sustained in one patient and sustained in
the other patientl. In the latter patient, complete elimination of the slow path-
way and SF reentry was achieved by further RF applications approximately 1
cm above the ablation site for FS reentry.
Conclusion: Prevention of atypical AVN echoes does not necessarily abol-
ish the typical form of AVN reentry. This suggests that the atypical form is not
simply a "reverse" of the typical form of AVN reentry.
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1724-51 Retrograde Atrial Activation in Patients with
Atrioventricular Nodal Reentry: Evidence for a Single
Anterior Nodal Exit
Michael Biehl, Sanjay Deshpande, Jasbir Sra, Anwer Dhala, Zalmen Blanck, R.
Dent Underwood, Edward T. Keelan, Masood Akhtar, Mohammad Jazayeri. Sinai
SamaritanlSt Lukes Medical Center, Milwaukee, WI
Recent reports suggested different retrograde atrial break throughs dur-
ing right ventricular apical (RVA) pacing at cycle lengths (Cl) of >600 and
<500 msec or change in the atrial electrogram morphology with critically
timed ventricular premature beats (V2) during atioventricular nodal reentrant
tacycardia (AVNRT). These Observations were attributed to the presence of
anisotropic conduction properties and multiple anterior nodal exits. respec-
tively. We evaluated the sequence of retrograde atrial activation in 12 con-
secutive patients (pts) with AVNRT. Using hexa- or decapolar catheters with
2 mm interelectrode spacing, multiple electrograms were recorded from the
His bundle region, posteroseptal, and midseptal tricuspid annulus. Atrial acti-
vation was assessed during decremental (RVA) pacing at CL 700 to 400 msec
(50 msec decrements) and down to the cycle length of block thereafter (10
msec decrements). and during diastolic scanning of AVNRTwith V2 (10 msec
decrements).
The mean cycle length of tachycardia was 366 msec. The atrial retrograde
activation sequence during decremental RVA pacing was identical to that dur-
ing AVNRT for all pts. At critical coupling intervals, V2 could penetrate AVNRT
circuit as indicated by resetting the tachycardia cycle length in 9 pts. In each
patient, resetting or lack of resetting was associated with a change in mor-
phology in all intracardiac electrograms when the local V2 and A2 were sepa-
rated. The sequence of atrial activation remained unchanged and identical to
that during tachycardia in all pts.
Conclusion: These observations suggest that only one retrograde pathway
links the distal AV node to the anterior atrial septum. Change in electrogram
morphology is most likely due to isolating ventricular from atrial activation.
AVNRT could be reset from the atrium and from the ventricle at all sites
studied. In all cases, when the coupling intervals of premature extrastim-
uli were plotted against the return cycle (As-Ar), an increasing resetting re-
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1724-61 Resetting Responses During Atrioventricular Nodal
Reentrant Tachycardia Suggest an Anisotropic
Mechanism
Kevin M. Monahan. Noel G. Boyle, Marco Zardini, Panos Papageorgiou,
Joseph Zebede, Mark E. Josephson. Beth Israel Hospital, Boston, MA
We hypothesized that an anatomically determined circuit should have an
identical excitable gap regardless of the site of stimulation. while a func-
tional anisotropic circuit could show differences depending on stimulation
site. In order to explore the nature of the reentrant circuit. and to characterize
the excitable gap during atrioventricular nodal reentrant tachycardia (AVNRT),
we determined the resetting response patterns in eight patients with typical
AVNRT (meantachycardia cycle length (TCl) 346 ± 18 msec). Premature atrial
stimuli were delivered during tachycardia from the area of the slow pathway
(SPI in 7 patients, the fast pathway (FP) in 6 patients, and the ventricle (V)
in 7 patients and the subsequent return cycles (As-Ar) were analyzed. In all
patients. two or more sites were stimulated. Ventricular extrastimulation em-
ployed double extrastimuli such that the first extrastimulus did not interact
with the circuit and acted as a conditioning stimulus. The excitable gap was
defined as the range of coupling intervals from first reset to tachycardia ter-
mination.
Duration of Excitable Gap (msec) by Stimulation Site
AT pts were predominantly female. Othervvise, AT and ATYP were not sep-
arated by tc Cl or intervals before Ad, or by dynamic relationships of intervals
analysed by linear correlation. Thus, Ad is not a useful pharmacologic probe
for differentiation of AT from ATYP when tc terminates without prior AVnode
block.
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1724-41 Coexistence of Typical and Atypical Atrio-ventricular
Nodal Reentry: Evidence for MUltiple Pathways of
Slow Conduction
Marco Zardini, Noel G. Boyle, Kevin M. Monahan, Panos Papageorgiou, Mark
E. Josephson, Claudio D. Schuger. Beth Israel Hospital, Boston, MA
The nature of the atrio-ventricular nodal (AVN) reentry circuit is still a source
of debate. We studied two patients in which both typical (slow-fast, SF) AVN
reentrant tachycardia and atypical (fast-slow, FS) AVN reentrant echoes could
be elicited with atrial and ventricular stimulation respectively. Discontinu-
ous antegrade and retrograde AVN curves were present in both patients, as
shown below:
:~ :~~ 600.. .0 1i ~~ PRE~ :;;: 500 POOT~ 0 0 0
300 300
200 300 400 500 600 200 300 400 500 600
Al-A2 Vl-V2
Patient 1 2 3 4
FP 10 65 20
SP 35 80 90 40
V 35 75 45
5 6
30 20
20
50 50
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20
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8
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Mean
26 ± 21
43 ± 30
42 ± 19
OfoTCL
7
12
12
